AGA Family of Websites: Gastro.org
Search

New podcast series explores the latest in C. difficile

Learn the latest on caring for C. diff patients with Drs. Paul Feuerstadt and Sahil Khanna.
C. Difficile: Preparing the field for change
C. Difficile: Preparing the field for change

As one of the most commonly reported bacterial infections, staying up to date on the latest in C. difficile is critical for providing the best possible care for your patients. AGA’s new on-demand program, C. difficile: Preparing the Field for Change, is a six-part podcast series that outlines effective approaches to patient-centered care that will transform your practice. 

Each 30-minute episode delves into a different topic — from microbiome therapy and FMT to documenting patient history — that will help you improve patient outcomes and reduce the risk of complications.

Tune in wherever you listen to podcasts! Click the episode names below to listen on AGA University and claim CME credit, or subscribe to Inside Scope on Apple or Google to stay up to date on new episodes.

  • Risk factors

    Drs. Paul Feuerstadt and Sahil Khanna cover risk factors for initial and recurrent C. difficile infection. This episode was originally released as a bonus episode in November 2022.

  • Microbiota changes

    Drs. Paul Feuerstadt and Sahil Khanna describe the shifts in the microbiota with C. difficile infection. This episode was originally released as a bonus episode in November 2022. 

  • Reconciling guideline differences for testing and treatment

    Drs. Paul Feuerstadt and Sahil Khanna are joined by guest Dr. Colleen Kelly to discuss how to reconcile guideline differences for testing and treatment of C. difficile.

  • Case management and transitions of care

    Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Rebecca Perez and Cheri Lattimer to discuss case management and transitions of care in C. difficile infection.

  • Impact of rCDI on patients and their lives

    Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Dr. Kevin Garey and a patient to discuss the impact of recurrent CDI on patients and their lives. 

This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.

AGA Clinical Guidance
Evidence-based recommendations.

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.

X